Background: We aimed to explore the relation of XPD and XPF variants with non-small cell lung cancer (NSCLC) risk and the effect of these variants on the sensitivity to cis
Technological advancements in the Non-Small Cell Lung Cancer industry are shaping the future market landscape. The report evaluates innovation-driven growth and how emerging technologies are transform